144 related articles for article (PubMed ID: 8408732)
1. Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial.
Chu S; Wilson DS; Deaton RL; Mackenthun AV; Eason CN; Cavanaugh JH
J Clin Pharmacol; 1993 Aug; 33(8):719-26. PubMed ID: 8408732
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin pharmacokinetics in healthy young and elderly volunteers.
Chu SY; Wilson DS; Guay DR; Craft C
J Clin Pharmacol; 1992 Nov; 32(11):1045-9. PubMed ID: 1474166
[TBL] [Abstract][Full Text] [Related]
3. Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics.
Chu SY; Granneman GR; Pichotta PJ; Decourt JP; Girault J; Fourtillan JB
J Clin Pharmacol; 1993 May; 33(5):480-5. PubMed ID: 8331208
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses.
Chu SY; Sennello LT; Bunnell ST; Varga LL; Wilson DS; Sonders RC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2447-53. PubMed ID: 1489187
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
Womble AY; Giguère S; Lee EA; Vickroy TW
Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
[TBL] [Abstract][Full Text] [Related]
6. Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.
Burkhardt O; Borner K; Stass H; Beyer G; Allewelt M; Nord CE; Lode H
Scand J Infect Dis; 2002; 34(12):898-903. PubMed ID: 12587622
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin clinical pharmacokinetics.
Fraschini F; Scaglione F; Demartini G
Clin Pharmacokinet; 1993 Sep; 25(3):189-204. PubMed ID: 8222460
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between ritonavir and clarithromycin.
Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
Mainz D; Borner K; Koeppe P; Kotwas J; Lode H
J Antimicrob Chemother; 2002 Nov; 50(5):699-706. PubMed ID: 12407126
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C
Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108
[TBL] [Abstract][Full Text] [Related]
12. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a clarithromycin suspension in infants and children.
Gan VN; Chu SY; Kusmiesz HT; Craft JC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2478-80. PubMed ID: 1489191
[TBL] [Abstract][Full Text] [Related]
14. Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects.
Lee CM; Jung EH; Byeon JY; Kim SH; Jang CG; Lee YJ; Lee SY
Arch Pharm Res; 2019 Dec; 42(12):1101-1106. PubMed ID: 31820397
[TBL] [Abstract][Full Text] [Related]
15. A phase I dose-ranging safety and pharmacokinetics study of a novel oral thromboxane synthase inhibitor, FCE 22, 178.
Li RC; Narang PK; Lewis RC; Hatfield NZ; Rossi DT; Colborn DC
J Clin Pharmacol; 1993 Apr; 33(4):373-80. PubMed ID: 8473553
[TBL] [Abstract][Full Text] [Related]
16. The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration.
Tsang KW; Roberts P; Read RC; Kees F; Wilson R; Cole PJ
J Antimicrob Chemother; 1994 Feb; 33(2):289-97. PubMed ID: 8182010
[TBL] [Abstract][Full Text] [Related]
17. Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers.
Kees F; Wellenhofer M; Grobecker H
Infection; 1995; 23(3):168-72. PubMed ID: 7499006
[TBL] [Abstract][Full Text] [Related]
18. Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial.
Chu S; Park Y; Locke C; Wilson DS; Cavanaugh JC
J Clin Pharmacol; 1992 Jan; 32(1):32-6. PubMed ID: 1531484
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin pharmacokinetics in the desert tortoise (Gopherus agassizii).
Wimsatt JH; Johnson J; Mangone BA; Tothill A; Childs JM; Peloquin CA
J Zoo Wildl Med; 1999 Mar; 30(1):36-43. PubMed ID: 10367642
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor.
Moore KH; Cass LM; Dallow N; Hardman TC; Jones A; Boyce M; Prince WT
Eur J Clin Pharmacol; 2001; 56(11):805-11. PubMed ID: 11294370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
